Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry

Faouzi Saliba, Sébastien Dharancy, Ephrem Salamé, Filoména Conti, Daniel Eyraud, Sylvie Radenne, Térésa Antonini, Olivier Guillaud, Jean Guguenheim, Martine Neau‐Cransac, Eléonora Demartin, Guillaume Lasailly, Christophe Duvoux, Rodolphe Sobesky, Audrey Coilly, Sylvie Tresson, Valérie Cailliez, Olivier Boillot, Georges Philippe Pageaux, Didier Samuel, Yvon Calmus, Jérôme Dumortier – 31 August 2020 – Longterm use of a calcineurin inhibitor (CNI)–based regimen is one of the major reasons for chronic renal failure in liver transplantation recipients (LTRs).

Reply:

Andrew J. Brooks, Mayumi Ishikawa, Manuel A. Fernández‐Rojo, Julian P. Vivian, Jamie Rossjohn, Michael J. Waters – 31 August 2020

Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes

Daryl T.Y. Lau, Lilia Ganova‐Raeva, Junyao Wang, Douglas Mogul, Raymond T. Chung, Mauricio Lisker‐Melman, Kyong‐Mi Chang, Obaid S. Shaikh, Harry L.A. Janssen, Abdus S. Wahed, Anna S. Lok, for the Hepatitis B Research Network – 29 August 2020

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes

Zobair M Younossi, Vincent Wai‐Sun Wong, Quentin M. Anstee, Manuel Romero‐Gomez, Michael H. Trauner, Stephen A. Harrison, Eric J. Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P. Myers, Zachary Goodman, Maria Stepanova – 28 August 2020 – Fatigue and pruritus are common in patients with chronic liver diseases of all etiologies, but clinical awareness is mostly restricted to those with cholestatic liver diseases. We assessed the impact of fatigue and pruritus on patient‐reported outcomes (PROs) of patients with advanced nonalcoholic steatohepatitis (NASH).

Subscribe to